secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2025-08-21T23:59:59+00:00
Accession:  0001193125-25-184625
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta exchanges $700M of 1.25% notes due 2027 for new 4.875% notes due 2030, stock, and cash
--------------------------------------------------------------------------------

- Exchanged ~$700M existing 1.25% convertible notes for $602M new 4.875% notes due 2030, $110M stock, and ~$123.3M cash.
- New notes conversion price ~$60/share, representing a 191.5% premium over the $20.58 Aug 20 closing price.
- Private placement of $20M common stock to J. Wood Capital Advisors at price with floor of $14.41/share.
- Up to 835,765 fee shares may be issued to J. Wood Capital Advisors for advisory services.
- Exchange expected to close Aug 28, 2025, subject to customary closing conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000119312525184625/0001193125-25-184625-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000119312525184625/d938350d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-184625

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer